These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25392271)

  • 1. Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis.
    Rotllan N; Chamorro-Jorganes A; Araldi E; Wanschel AC; Aryal B; Aranda JF; Goedeke L; Salerno AG; Ramírez CM; Sessa WC; Suárez Y; Fernández-Hernando C
    FASEB J; 2015 Feb; 29(2):597-610. PubMed ID: 25392271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt2/LDLr double knockout mice display impaired glucose tolerance and develop more complex atherosclerotic plaques than LDLr knockout mice.
    Rensing KL; de Jager SC; Stroes ES; Vos M; Twickler MT; Dallinga-Thie GM; de Vries CJ; Kuiper J; Bot I; von der Thüsen JH
    Cardiovasc Res; 2014 Feb; 101(2):277-87. PubMed ID: 24220638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice.
    Babaev VR; Hebron KE; Wiese CB; Toth CL; Ding L; Zhang Y; May JM; Fazio S; Vickers KC; Linton MF
    J Lipid Res; 2014 Nov; 55(11):2296-308. PubMed ID: 25240046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
    Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
    Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr
    Jeurissen MLJ; Walenbergh SMA; Houben T; Gijbels MJJ; Li J; Hendrikx T; Oligschlaeger Y; van Gorp PJ; Binder CJ; Donners MMPC; Shiri-Sverdlov R
    Atherosclerosis; 2016 Dec; 255():59-65. PubMed ID: 27816810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of bone marrow transplantation on lipoprotein metabolism and atherosclerosis in LDL receptor-knockout mice.
    Herijgers N; Van Eck M; Groot PH; Hoogerbrugge PM; Van Berkel TJ
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):1995-2003. PubMed ID: 9351364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis.
    Hamers AA; Vos M; Rassam F; Marinković G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ
    Circ Res; 2012 Feb; 110(3):428-38. PubMed ID: 22194623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice.
    Babaev VR; Ding L; Zhang Y; May JM; Ramsey SA; Vickers KC; Linton MF
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):156-169. PubMed ID: 30567482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.
    Hendrikx T; Jeurissen ML; van Gorp PJ; Gijbels MJ; Walenbergh SM; Houben T; van Gorp R; Pöttgens CC; Stienstra R; Netea MG; Hofker MH; Donners MM; Shiri-Sverdlov R
    FEBS J; 2015 Jun; 282(12):2327-38. PubMed ID: 25817537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
    Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
    Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice.
    Bie J; Zhao B; Ghosh S
    Am J Physiol Regul Integr Comp Physiol; 2011 Oct; 301(4):R967-74. PubMed ID: 21795638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner.
    Wezel A; van der Velden D; Maassen JM; Lagraauw HM; de Vries MR; Karper JC; Kuiper J; Bot I; Quax PH
    Atherosclerosis; 2015 Jan; 238(1):132-9. PubMed ID: 25484103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
    Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
    Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
    Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.